A Study to Characterize the Cardiac Phenotype of Individuals With Friedreich's Ataxia (CARFA Study)
- Conditions
- Friedreich's Ataxia
- Interventions
- Procedure: Cardiac magnetic resonance imaging (CMR)Procedure: Exercise-stress testProcedure: Echocardiography (ECHO)Procedure: Cardiac-related blood studies
- Registration Number
- NCT02840669
- Lead Sponsor
- Adverum Biotechnologies, Inc.
- Brief Summary
Friedreich's ataxia (FA) is an autosomal recessive disease with an incidence of 1/50,000 in the Caucasian population. The main manifestations of FA are progressive sensory and cerebellar ataxia and cardiomyopathy (CM). It is the most common form of inherited ataxia. A severe CM affects \~60% of FA patients, mostly young adults, and leads to cardiac failure then death. Currently, no therapy can change the course of this severe cardiomyopathy.
This study is designed to characterize the cardiac manifestations of FA using cardiac magnetic resonance (CMR), echocardiography, serum cardiac biomarkers and evaluation of fatigue severity, in the context of the neurological disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description Healthy Volunteers (Controls) Cardiac magnetic resonance imaging (CMR) - Friedreich's Ataxia Cardiac magnetic resonance imaging (CMR) - Friedreich's Ataxia Exercise-stress test - Friedreich's Ataxia Echocardiography (ECHO) - Friedreich's Ataxia Cardiac-related blood studies - Healthy Volunteers (Controls) Echocardiography (ECHO) - Healthy Volunteers (Controls) Cardiac-related blood studies - Healthy Volunteers (Controls) Exercise-stress test -
- Primary Outcome Measures
Name Time Method Echocardiogram 2 hours Level of cardiac biomarkers in serum 30 minutes Fatigue Severity Scale 30 minutes Exercise-stress test 2 hours Cardiac magnetic resonance imaging (CMR) 2 hours
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hôpital Pitié-Salpêtrière, AP-HP
🇫🇷Paris, France